Keith Stockerl-Goldstein

9PUBLICATIONS
99CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHumoural immunology and immunochemistryHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 02, 2026
Efficacy and Safety of Belantamab Mafodotin with Bortezomib plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: The DREAMM-6 Arm B Trial.

Rakesh Popat, Bradley Augustson, Paul Cannell

|Mar 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma.

Alice Y Zhou, Nancy D Marin, Sadia Afrin

|Oct 04, 2024
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response.

Meagan A Jacoby, Eric D Duncavage, Ajay Khanna

|May 06, 2023
A Single Reference Interval for Interpreting Serum Free Light Chains across Patients with Varying Renal Function.

Vahid Azimi, Michael Slade, Mark Fiala

|Apr 17, 2023
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.

Zachary D Crees, Michael P Rettig, Reyka G Jayasinghe

|Mar 09, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19.

Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch

Pageof 2

Frequent Collaborators

3 joint publications

Geoffrey L Uy

3 joint publications

Celia C Cubitt

3 joint publications

Pamela Wong

3 joint publications

Jennifer A Foltz